At a glance: Semax is a seven-amino-acid peptide built from a fragment of the hormone ACTH. It has been a registered prescription medicine in Russia for decades, mainly for stroke-related conditions, and is usually given as a nasal spray. It is not FDA-approved. In July 2026 an FDA advisory committee narrowly recommended allowing it in compounding, but that vote is non-binding and nothing has changed legally yet.
What is Semax?
Semax is a synthetic heptapeptide (seven amino acids: Met-Glu-His-Phe-Pro-Gly-Pro). It was developed by scientists at the Institute of Molecular Genetics of the Russian Academy of Sciences and first described in the scientific literature in 1991.
It is based on ACTH(4-10), a short piece of adrenocorticotropic hormone. Full ACTH tells the adrenal glands to release cortisol; this fragment was chosen because it showed effects on the brain without that hormonal action. A three-amino-acid tail (Pro-Gly-Pro) was added to slow its breakdown in the body.
How does Semax work?
Most of what is known about Semax's mechanism comes from rat and cell studies, largely from Russian research groups. The main proposed effects:
- Raises BDNF: in rats, Semax quickly increased brain-derived neurotrophic factor and its receptor (TrkB) in the hippocampus, a memory-related brain region. BDNF supports neuron survival and the formation of new connections.
- Affects dopamine and serotonin signaling in animal studies, which may relate to reported effects on attention and mood.
- Dampens inflammation and protects neurons under low-oxygen or glutamate stress in animal models of stroke.
- Slows breakdown of enkephalins (natural pain- and stress-modulating peptides), an effect it shares with the related peptide Selank.
What the research shows so far
| Area | What has been studied | Strength of evidence |
|---|---|---|
| Stroke and brain ischemia | Rat models show protective changes in gene expression and brain proteins; Russian clinical use after ischemic stroke | Animal data plus mostly small Russian clinical studies |
| Memory and learning | Improved learning and BDNF signaling in rats | Animal studies; little rigorous human data |
| Attention and mental fatigue | Small Russian studies and user reports | Weak |
| Mood and stress | Antidepressant-like and anti-anxiety-like effects in animals | Animal studies only |
Most human studies are small, published in Russian, and have not been replicated in large Western trials.
Why it gets attention
- It is an actual registered medicine in Russia, which sets it apart from most research peptides
- Nootropic interest: people look it up for focus, memory and mental stamina
- Stroke and brain-injury research gives it a medical backstory beyond biohacking
- The 2026 FDA advisory vote brought it into US news coverage
How it is given
Semax is broken down in the gut, so it is not taken by mouth. In Russia it is supplied as nasal drops, and some research and compounded products are given by injection under the skin. Effects are reported to last hours to about a day. There is no FDA-approved dosing in the US, and this page does not provide dosing guidance.
What about side effects?
In Russian clinical use and user reports, the most common complaints are mild nasal irritation, headache, and temporary overstimulation or tiredness. Less often, people report anxiety, irritability or poor sleep, particularly at higher amounts. Long-term safety data outside Russian clinical experience are limited, and interactions with other drugs have not been studied systematically.
People who are pregnant or breastfeeding, have a history of mania or psychosis, or take medications that affect brain chemistry should not use it without medical supervision.
Regulatory status
- Russia: a registered prescription drug, used mainly for stroke and other cerebrovascular conditions; on Russia's list of vital and essential medicines since 2011.
- United States: not FDA-approved for any use. In July 2026 the FDA's Pharmacy Compounding Advisory Committee narrowly voted to recommend Semax for the list of substances compounding pharmacies may use, even though FDA's own reviewers recommended against it, citing a lack of clinical data.
- The vote is advisory, not an approval. Until FDA completes a formal rulemaking, nothing has been added to the list.
- Products sold online as "research use only" are unregulated and not intended for human use.
Semax vs Adamax
Adamax is a newer, modified version of Semax with an added adamantane group, marketed as longer-lasting and stronger. Semax has decades of (mostly Russian) research and registered medical use; Adamax has essentially no published research. Our Adamax page covers it in detail.
| Semax | Adamax | |
|---|---|---|
| Structure | ACTH(4-10)-based heptapeptide | Semax modified with N-acetyl and adamantane groups |
| Research | Decades of Russian research plus animal studies | No peer-reviewed studies or registered trials |
| Approval | Registered medicine in Russia | Not approved anywhere |
| US status | Not approved; recommended for compounding by an advisory panel (non-binding) | Not approved and not under FDA review |
The bottom line
Semax is one of the better-studied research peptides, with real medical use in Russia and plausible mechanisms from animal work. But the human evidence is mostly small and not independently replicated, it is not approved in the US, and the 2026 advisory vote did not change its legal status. Anyone considering it for cognition or brain health should talk with a licensed clinician.
Frequently asked questions
What is Semax?
A synthetic peptide based on a fragment of the hormone ACTH, given as a nasal spray in Russia.
How is Semax taken?
Nasal spray.
Is Semax FDA approved?
Not approved in the US; approved in Russia.
That means no regulator has reviewed its safety, effectiveness or manufacturing quality for this use.
What has research shown about Semax?
- Recovery after stroke in Russian clinical studies.
- Memory and attention in animal and small human studies.
What side effects have been reported?
- Nasal irritation
Serious or less common risks are listed in the Side Effects section above.
What is still unknown about its safety?
Most of it. Semax has not been through the trials that establish long-term safety in people, and products sold online are made by unregulated labs. Independent testing of online peptides has repeatedly found contents that do not match the label.
References
- Dolotov OV, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research. 2006;1117(1):54-60. View source
- Rodent study of Semax effects on brain gene expression and proteins after induced ischemia (PMC8855339). View source
- AJMC: FDA panel backs 6 peptides for compounding (July 2026). View source
- Mintz: FDA's advisory committee votes on peptides, what it does and doesn't mean (July 2026). View source
- Klearmind Clinics: Adamax vs Semax, differences, benefits and side effects. View source